NEW YORK (GenomeWeb News) – DxS will collaborate with drug developers Bristol-Myers Squibb and Eli lilly subsidiary ImClone Systems to continue development of a companion diagnostic for the drug cetuximab, which is marketed as Erbitux, in the US and Canada, DxS said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.